Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Glenmark Plans To Spin Out A US-Based ‘Innovation’ Business – And May Pull The Plug On Advair
Feb 19 2019
•
By
Dean Rudge
Spinning off its innovative assets will bring a “strong, heightened focus," Glenmark believes. • Source: Shutterstock
More from Strategy
More from Business